This is the authors' abstract. We don't add key points for this paper.
Platelet-type von Willebrand disease (PT-VWD), or pseudo-VWD, is a rare inherited platelet disorder characterized by an increased affinity of the platelet membrane glycoprotein Ibalpha receptor for normal von Willebrand factor leading to characteristic platelet hyperaggregability. As PT-VWD shares most of the clinical and laboratory features of subtype 2B VWD, the differential diagnosis between these two inherited bleeding disorders requires either platelet-mixing or molecular genetic studies. In this review, the main clinical, laboratory and therapeutic characteristics of PT-VWD are concisely reported.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Franchini et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: